Erika G. Martin

centers for disease control & prevention - usa

H指数:29

被引数:2,470

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Decade of the National Center for HIV, Viral Hepatitis, STD, and TB Prevention’s Epidemiologic and Economic Modeling Agreement

国家艾滋病、病毒性肝炎、性传播疾病和结核病预防中心流行病学与经济学模型协议的十年

Public Health Reports

IF2.5

2025-12-040

Short-Term Impact of Changes in Public Health Information Systems on Sexually Transmitted Infection Surveillance Data Quality

SEXUALLY TRANSMITTED DISEASES

IF1.7

2025-11-010

PRE

Disease Intervention Specialist-Delivered Interventions and Other Partner Services for HIV and Sexually Transmitted Infections: A Systematic Review

AMERICAN JOURNAL OF PREVENTIVE MEDICINE

IF4.5

2025-01-011

PRE

A novel and highly efficient biomimetic capture approach for the isolation and characterization of circulating metastatic cancer cell clusters from lung cancer patients

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Modeling the Potential Impact of Missing Race and Ethnicity Data in Infectious Disease Surveillance Systems on Disparity Measures: Scenario Analysis of Different Imputation Strategies

对传染病监测系统中缺失的种族和种族数据对差异度量的潜在影响进行建模: 不同估算策略的情景分析

JMIR PUBLIC HEALTH AND SURVEILLANCE

IF3.9

2022-11-099

OAAI

Enhancing the usability and usefulness of open government data: A comprehensive review of the state of open government data visualization research

增强开放政府数据的可用性和有用性 -- 开放政府数据可视化研究现状综述

GOVERNMENT INFORMATION QUARTERLY

IF10

2022-01-0139

PRE

Open government data portals: Predictors of site engagement among early users of Health Data NY

开放的政府数据门户: 纽约健康数据早期用户网站参与度的预测因素

GOVERNMENT INFORMATION QUARTERLY

IF10

2021-10-017

PREAI

Resilience-Focused HIV Care to Promote Psychological Well-Being During COVID-19 and Other Catastrophes

以复原力为重点的艾滋病毒护理，以促进新型冠状病毒肺炎和其他灾难期间的心理健康

FRONTIERS IN PUBLIC HEALTH

IF3.4

2021-08-047

OAAI

Sociodemographic Characteristics and Inequities Associated With Access to In-Person and Remote Elementary Schooling During the COVID-19 Pandemic in New York State

JAMA NETWORK OPEN

IF9.7

2021-07-1511

OAAI

An in vitro pharmacodynamic spiking study of befovacimab, a tissue factor pathway inhibitor monoclonal antibody, in blood samples from patients with severe FVIII deficiency

HAEMOPHILIA

IF3

2021-04-293

PREAI

Employing telehealth within HIV care: advantages, challenges, and recommendations

AIDS

IF3.1

2021-03-2219

A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018

PUBLIC HEALTH REPORTS

IF2.5

2020-07-3123

OAAI

Simulating the End of AIDS in New York: Using Participatory Dynamic Modeling to Improve Implementation of the Ending the Epidemic Initiative

PUBLIC HEALTH REPORTS

IF2.5

2020-07-316

OAAI

Ending the HIV Epidemic: New York's Quest to Become the First State to Reduce HIV Prevalence

PUBLIC HEALTH REPORTS

IF2.5

2020-07-319

OAAI

Association of US Households' Disaster Preparedness With Socioeconomic Characteristics, Composition, and Region

JAMA NETWORK OPEN

IF9.7

2020-04-2729

OAAI

Fighting obesity at the local level? An analysis of predictors of local health departments' policy involvement

PREVENTIVE MEDICINE

IF3.2

2020-04-017

PREAI

A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding

一种合成的肝素模拟物，可在体内变构抑制XIa因子并减少血栓形成，而不会增加出血风险

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2019-12-0126

OAAI

Factors associated with incomplete toxicology reporting in drug overdose deaths, 2010-2016

ANNALS OF EPIDEMIOLOGY

IF3

2019-10-0122

PREAI

Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmas

HAEMOPHILIA

IF3

2019-07-2335

PREAI

Use of global assays to monitor emicizumab prophylactic therapy in patients with haemophilia A with inhibitors

HAEMOPHILIA

IF3

2019-02-1213

PREAI

Erika G. Martin

个人简介

教育背景

工作经历

荣誉奖项

研究方向